A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure

(2019) Liriye Kurtovic et al.   BMC Medicine

Persistence of HB sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

(2019) Pierre Van Damme et al.   JOURNAL OF VIRAL HEPATITIS

Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques

(2019) Amelia Escolano et al.   NATURE

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity

(2019) Jo-Anne Chan et al.   PLoS One

Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years

(2019) Miniar Tfifha et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice

(2019) Morten L. Govasli et al.   VACCINE

Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination

(2018) Theodora Ulli Jordanka Bruun et al.   ACS Nano

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

(2018) Innocent Valéa et al.   Human Vaccines & Immunotherapeutics

New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue

(2018) Karl D. Brune et al.   Frontiers in Immunology

Virus-like particle display of HER2 induces potent anti-cancer responses

(2018) Arianna Palladini et al.   OncoImmunology

Global HBV burden: guesstimates and facts

(2018) Dina Ginzberg et al.   Hepatology International

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

(2018) Frank Lennartz et al.   Nature Communications

Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children

(2018) Itziar Ubillos et al.   BMC Medicine

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

(2018) Prasun Kundu et al.   Nature Communications

HPV vaccines – A review of the first decade

(2017) Diane M. Harper et al.   GYNECOLOGIC ONCOLOGY

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform

(2017) John R. Gallagher et al.   VIROLOGY

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25

(2017) Stephen W. Scally et al.   Nature Communications

Autocatalytic association of proteins by covalent bond formation: a Bio Molecular Welding toolbox derived from a bacterial adhesin

(2017) J. Bonnet et al.   Scientific Reports

Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines

(2017) Darren B. Leneghan et al.   Scientific Reports

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

(2017) Katharine A. Collins et al.   Scientific Reports

The effect of preexisting anti-carrier immunity on subsequent responses to CRM197or Qb-VLP conjugate vaccines

(2016) Michael J. McCluskie et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Programmable polyproteams built using twin peptide superglues

(2016) Gianluca Veggiani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay

(2016) Kazutoyo Miura et al.   VACCINE

Kinetic Controlled Tag-Catcher Interactions for Directed Covalent Protein Assembly

(2016) Lee Ling Tan et al.   PLoS One

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

(2016) Yuanyuan Li et al.   Scientific Reports

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

(2016) Karl D. Brune et al.   Scientific Reports

Toward the development of effective transmission-blocking vaccines for malaria

(2015) Daria Nikolaeva et al.   Expert Review of Vaccines

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Mosaic RNA Phage VLPs Carrying Domain III of the West Nile Virus E Protein

(2014) Indulis Cielens et al.   MOLECULAR BIOTECHNOLOGY

Superglue from bacteria: unbreakable bridges for protein nanotechnology

(2014) Gianluca Veggiani et al.   TRENDS IN BIOTECHNOLOGY

Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays

(2013) Kazutoyo Miura et al.   PLoS One

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response

(2013) Yong Poovorawan et al.   Human Vaccines & Immunotherapeutics

Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin

(2012) B. Zakeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

(2012) Natasha Kushnir et al.   VACCINE

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41

(2012) C. Pastori et al.   VIROLOGY

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines

(2010) Alain C. Tissot et al.   PLoS One

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

(2010) Andrea Jegerlehner et al.   VACCINE

Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

(2009) Rafael Cubas et al.   JOURNAL OF IMMUNOTHERAPY

Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand

(2009) Yong Poovorawan et al.   VACCINE

Nanoparticles target distinct dendritic cell populations according to their size

(2008) Vania Manolova et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

(2008) Yimin Wu et al.   PLoS One

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

(2008) Marina De Filette et al.   VACCINE